This study has some specific requirements for its electronic data capture and data management needs
Cambridge, MA (PRWEB) April 29, 2009
OpenClinica Enterprise has been selected as the electronic data capture and clinical data management solution for the Abuja Heart Study, a long-term cardiovascular study involving up to 10,000 patients from multiple sites across Nigeria.
Collaborators on the study include the Harvard Clinical Research Institute, Byrne Healthcare, Federal Ministry of Health Nigeria, and Healthsystem Plus.
Recent statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years. However, data is not yet available to determine the magnitude and social burden of the disease or the distribution within the population of many countries, including Nigeria.
In many ways analogous to the well-known Framingham Heart Study, the Abuja Heart Study will help scientists understand the role socio-cultural and hereditary factors play in a specific population in order to adopt targeted policies for prevention and control.
"This study has some specific requirements for its electronic data capture and data management needs," said Study Director, Uchenna Onyeachom. "We require a lightweight, standards-based, and regulatory compliant system that can function well in resource constrained settings and is intuitive to remote users with minimal training. The flexible OpenClinica technology and enterprise open source approach from Akaza provide us with these benefits and give us the necessary assurance that many years from now our study will still be run with robust and well-supported software."
Fore more information about The Abuja Heart Study, see http://abujaheartstudy.org.
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.
About Healthsystem Plus®:
Healthsystem Plus is a private non-profit international health organization. The organization focuses on developing programs that strengthen health systems and close gaps in healthcare disparities. Healthsystem Plus collaborates with policy makers academic institutions around the world for an effective and sustainable health programs. For more information see http://www.healthsystemplus.org.
About Akaza Research®:
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world's most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See http://www.akazaresearch.com.
# # #